Search research articles
Contact Us
Filters
Showing results (1-10 of 71) with videos related to
Page
of 8
Sort By:
Journal of Pain and Symptom Management
|
November 1, 1995
The use of propofol in palliative medicine
J Moyle
Expert Opinion on Investigational Drugs
|
August 1, 1997
Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice
G J Moyle
Expert Opinion on Investigational Drugs
|
July 5, 2005
Saquinavir-soft gel: establishing saquinavir in HAART regimens
G J Moyle
Expert Opinion on Investigational Drugs
|
February 1, 1997
Stavudine:pharmacology,clinical use and future role
G J Moyle
Drugs
|
August 1, 1996
Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences
G J Moyle
Current HIV/AIDS Reports
|
August 11, 2005
Plastic surgical approaches for HIV-associated lipoatrophy
Graeme J Moyle
Current Opinion in Infectious Diseases
|
April 20, 2002
Considerations in the choice of protease inhibitor-sparing regimens in initial therapy for HIV-1 infection
Graeme J. Moyle
The Journal of Antimicrobial Chemotherapy
|
February 14, 1998
Current knowledge of HIV-1 reverse transcriptase mutations selected during nucleoside analogue therapy: the potential to use resistance data to guide clinical decisions
G J Moyle
Expert Opinion on Investigational Drugs
|
July 5, 2005
Efavirenz: shifting the HAART paradigm in adult HIV-1 infection
G J Moyle
FEBS Letters
|
April 15, 1978
Cytochrome c oxidase is not a proton pump
J Moyle, P Mitchell
Page
of 8
Search research articles
Search
Showing results (1-10 of 71) with videos related to
Sort By:
Page
of 8
Journal of Pain and Symptom Management
|
November 1, 1995
The use of propofol in palliative medicine
J Moyle
Expert Opinion on Investigational Drugs
|
August 1, 1997
Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice
G J Moyle
Expert Opinion on Investigational Drugs
|
July 5, 2005
Saquinavir-soft gel: establishing saquinavir in HAART regimens
G J Moyle
Expert Opinion on Investigational Drugs
|
February 1, 1997
Stavudine:pharmacology,clinical use and future role
G J Moyle
Drugs
|
August 1, 1996
Use of viral resistance patterns to antiretroviral drugs in optimising selection of drug combinations and sequences
G J Moyle
Current HIV/AIDS Reports
|
August 11, 2005
Plastic surgical approaches for HIV-associated lipoatrophy
Graeme J Moyle
Current Opinion in Infectious Diseases
|
April 20, 2002
Considerations in the choice of protease inhibitor-sparing regimens in initial therapy for HIV-1 infection
Graeme J. Moyle
The Journal of Antimicrobial Chemotherapy
|
February 14, 1998
Current knowledge of HIV-1 reverse transcriptase mutations selected during nucleoside analogue therapy: the potential to use resistance data to guide clinical decisions
G J Moyle
Expert Opinion on Investigational Drugs
|
July 5, 2005
Efavirenz: shifting the HAART paradigm in adult HIV-1 infection
G J Moyle
FEBS Letters
|
April 15, 1978
Cytochrome c oxidase is not a proton pump
J Moyle, P Mitchell
Page
of 8